Inventor · disambiguated record
Hongtao Xu
Also filed as: XU HONGTAO
11 granted patents·6 pending applications·4 citations·filing 2014–2023
79Inventor score
Files withHOFFMANN LA ROCHE9TIANJIN INST IND BIOTECHNOLOGY CAS5THE SIXTH ELEMENT CHANGZHOU METERIALS TECH CO LTD1UNIV SHANGHAI TECHNOLOGY1XIAO FEI1
Top patents by PatentIndex Score
17 records- 0167US10006063B2Recombinant Escherichia coli for producing succinate acid and application thereofTIANJIN INST IND BIOTECHNOLOGY CAS·Filed 2014·Granted Jun 26, 2018·2 cites·13 claims
- 0266US9982142B2Zinc-rich epoxy anti-corrosion coating and preparation method thereofTHE SIXTH ELEMENT CHANGZHOU METERIALS TECH CO LTD·Filed 2014·Granted May 29, 2018·2 cites·15 claims
- 0365US2024140933A1Oxoindoline compound for the treatment of inflammatory diseases or cancerHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0462US2025027120A1Acid-resistant yeast strain for efficient production of succinic acid, and construction method therefor and use thereofTIANJIN INST IND BIOTECHNOLOGY CAS·Filed 2022·Application pending·0 cites
- 0562US2025011822A1Acid-resistant yeast strain for efficient production of l-malic acid, and construction method therefor and use thereofTIANJIN INST IND BIOTECHNOLOGY CAS·Filed 2022·Application pending·0 cites
- 0657US12503471B2Triazatricycle compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2020·Granted Dec 23, 2025·0 cites·15 claims
- 0757US12486273B2Hydro-1H-pyrrolo[1,2-a]pyrazine compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2020·Granted Dec 2, 2025·0 cites·18 claims
- 0857US12421240B2Hydropyrazino[1,2-d][1,4]diazepine compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2020·Granted Sep 23, 2025·0 cites·16 claims
- 0956US12421229B2Hydropyrido[1,2-α]pyrazine compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2020·Granted Sep 23, 2025·0 cites·13 claims
- 1053US2023041743A11,8-naphthyridin-2-one compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1152US11548884B2Cyclic amidine compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2018·Granted Jan 10, 2023·0 cites·12 claims
- 1252US2023002375A1Hydropyrazino[1,2-b]isoquinoline compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1349US12157746B2Tetrahydro-1H-pyrazino[2,1-a]isoindolylquinoline compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2019·Granted Dec 3, 2024·0 cites·19 claims
- 1449US2022017471A1Functionality independent labeling of organic compoundsUNIV SHANGHAI TECHNOLOGY·Filed 2019·Application pending·0 cites
- 1543US9944957B2Recombinant Escherichia coli for producing D-lactate and use thereofTIANJIN INST IND BIOTECHNOLOGY CAS·Filed 2014·Granted Apr 17, 2018·0 cites·12 claims
- 1643US9816124B2Recombinant microorganism for preparing terpenoid and method for constructing recombinant microorganismTIANJIN INST IND BIOTECHNOLOGY CAS·Filed 2014·Granted Nov 14, 2017·0 cites·10 claims
- 1742US10471154B2Spirocyclic indolone polyethylene glycol carbonate compound, composition, preparation method and use thereofXIAO FEI·Filed 2016·Granted Nov 12, 2019·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Hongtao Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →